A multidisciplinary approach to study a couple of monozygotic twins discordant for the chronic fatigue syndrome: A focus on potential salivary biomarkers

Journal of Translational Medicine

Volumn 11, Issue 1, 2013, Pages

  Ciregia, Federica ^a   Giusti, Laura ^a   Da Valle, Ylenia ^a   Donadio, Elena ^a   Consensi, Arianna ^a   Giacomelli, Camillo ^a   Sernissi, Francesca ^a   Scarpellini, Pietro ^a   Maggi, Fabrizio ^b   Lucacchini, Antonio ^a   Bazzichi, Laura ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY HOSPITAL OF PISA   (Italy)

Author keywords

Chronic fatigue syndrome; Proteomics; Two dimensional electrophoresis; Whole saliva

Indexed keywords

ALPHA2 GLYCOPROTEIN; CYCLOPHILIN A; CYSTATIN C; PROTEIN 14 3 3; PROTEIN 14 3 3 DELTA; PROTEIN 14 3 3 ZETA; PSORIASIN; SALIVA PROTEIN; UNCLASSIFIED DRUG; ZINC ALPHA2 GLYCOPROTEIN;

ADULT; AMINO ACID SEQUENCE; ARTICLE; CASE REPORT; CHRONIC FATIGUE SYNDROME; COMPUTER PROGRAM; CONTROLLED STUDY; DOWN REGULATION; ELECTROSPRAY MASS SPECTROMETRY; FIBROMYALGIA IMPACT QUESTIONNAIRE; FUNCTIONAL ASSESSMENT OF CHRONIC ILLNESS THERAPY FATIGUE SCALE; HUMAN; INFLAMMATION; LIQUID CHROMATOGRAPHY; MALE; MONOZYGOTIC TWINS; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PATHOGENESIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEOMICS; QUANTITATIVE ANALYSIS; SALIVA ANALYSIS; SHORT FORM 36; TANDEM MASS SPECTROMETRY; TWIN DISCORDANCE; TWO DIMENSIONAL ELECTROPHORESIS; UPREGULATION; VISUAL ANALOG SCALE; WESTERN BLOTTING;

ADULT; BIOLOGICAL MARKERS; BLOTTING, WESTERN; COGNITION; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FATIGUE SYNDROME, CHRONIC; HUMANS; INTERDISCIPLINARY COMMUNICATION; MALE; MASS SPECTROMETRY; PROTEOMICS; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SALIVA; SIGNAL TRANSDUCTION; TWINS, MONOZYGOTIC;

EID: 84884785868     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-11-243     Document Type: Article

References (58)

1. Christley Y, Duffy T, Martin CR. A review of the definitional criteria for chronic fatigue syndrome. J Eval Clin Pract 2012, 18:25-31. 10.1111/j.1365-2753.2010.01512.x, 21029269.
2. Turnbull N, Shaw EJ, Baker R, Dunsdon S, Costin N, Britton G, Kuntze S, Norman R. Chronic fatigue syndrome/myalgic encephalomyelitis (or encephalopathy): diagnosis and management of CFS/ME in adults and children. NICE clinical guideline 2007, 53:1-317.
3. Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann Intern Med 1994, 121:953-959. 10.7326/0003-4819-121-12-199412150-00009, 7978722.
4. Bagnall AM, Whiting P, Richardson R, Sowden AJ. Interventions for the treatment and management of chronic fatigue syndrome/myalgic encephalomyelitis. Qual Saf Health Care 2002, 11:284-288. 10.1136/qhc.11.3.284, 1743629, 12486997.
5. Hannon KL, Peters S, Fisher L, Riste L, Wearden A, Lovell K, Turner P, Leech Y, Chew-Graham C. Developing resources to support the diagnosis and management of Chronic Fatigue Syndrome/Myalgic Encephalitis (CFS/ME) in primary care. A qualitative study. BMC Fam Pract 2012, 13:93. 10.1186/1471-2296-13-93, 3573921, 22998151.
6. Dinos S, Khoshaba B, Ashby D, White PD, Nazroo J, Wessely S, Bhui KS. A systematic review of chronic fatigue, its syndromes and ethnicity: prevalence, severity, co-morbidity and coping. Int J Epidemiol 2009, 38:1554-1570. 10.1093/ije/dyp147, 19349479.
7. Kerr JR, Petty R, Burke B, Gough J, Fear D, Sinclair LI, Mattey DL, Richards SC, Montgomery J, Baldwin DA, Kellam P, Harrison TJ, Griffin GE, Main J, Enlander D, Nutt DJ, Holgate ST. Gene expression subtypes in patients with chronic fatigue syndrome/myalgic encephalomyelitis. J Infect Dis 2008, 197:1171-1184. 10.1086/533453, 18462164.
8. Gow JW, Hagan S, Herzyk P, Cannon C, Behan PO, Chaudhuri A. A gene signature for post-infectious chronic fatigue syndrome. BMC Med Genomics 2009, 2:38. 10.1186/1755-8794-2-38, 2716361, 19555476.
9. Powell R, Ren J, Lewith G, Barclay W, Holgate S, Almond J. Identification of novel expressed sequences, up-regulated in the leucocytes of chronic fatigue syndrome patients. Clin Exp Allergy 2003, 33:1450-1456. 10.1046/j.1365-2222.2003.01745.x, 14519154.
10. Vernon SD, Unger ER, Dimulescu IM, Rajeevan M, Reeves WC. Utility of the blood for gene expression profiling and biomarker discovery in chronic fatigue syndrome. Dis Markers 2002, 18:193-199. 10.1155/2002/892374, 12590173.
11. Chapenko S, Krumina A, Logina I, Rasa S, Chistjakovs M, Sultanova A, Viksna L, Murovska M. Association of active human herpesvirus-6, -7 and parvovirus b19 infection with clinical outcomes in patients with myalgic encephalomyelitis/chronic fatigue syndrome. Adv Virol 2012, 2012:205085. 3426163, 22927850.
12. Maggi F, Bazzichi L, Sernissi F, Mazzetti P, Lanini L, Scarpellini P, Consensi A, Giacomelli C, Macera L, Vatteroni ML, Bombardieri S, Pistello M. Absence of xenotropic murine leukemia virus-related virus in Italian patients affected by chronic fatigue syndrome, fibromyalgia, or rheumatoid arthritis. Int J Immunopathol Pharmacol 2012, 25:523-529.
13. Alter HJ, Mikovits JA, Switzer WM, Ruscetti FW, Lo SC, Klimas N, Komaroff AL, Montoya JG, Bateman L, Levine S, Peterson D, Levin B, Hanson MR, Genfi A, Bhat M, Zheng H, Wang R, Li B, Hung GC, Lee LL, Sameroff S, Heneine W, Coffin J, Hornig M, Lipkin WI. A multicenter blinded analysis indicates no association between chronic fatigue syndrome/myalgic encephalomyelitis and either xenotropic murine leukemia virus-related virus or polytropic murine leukemia virus. MBio 2012, 3:e00266-12. 3448165, 22991430.
14. Tsibris AM. The end of the association between XMRV, MLV-like viruses and chronic fatigue syndrome. Virulence 2011, 2:493-494. 10.4161/viru.2.6.18518, 22186762.
15. Simmons G, Glynn SA, Komaroff AL, Mikovits JA, Tobler LH, Hackett J, Tang N, Switzer WM, Heneine W, Hewlett IK, Zhao J, Lo SC, Alter HJ, Linnen JM, Gao K, Coffin JM, Kearney MF, Ruscetti FW, Pfost MA, Bethel J, Kleinman S, Holmberg JA, Busch MP. Blood XMRV Scientific Research Working Group (SRWG): failure to confirm XMRV/MLVs in the blood of patients with chronic fatigue syndrome: a multi-laboratory study. Science 2011, 334:814-817. 10.1126/science.1213841, 3299483, 21940862.
16. Lerner AM, Ariza ME, Williams M, Jason L, Beqaj S, Fitzgerald JT, Lemeshow S, Glaser R. Antibody to Epstein-Barr virus deoxyuridine triphosphate nucleotidohydrolase and deoxyribonucleotide polymerase in a chronic fatigue syndrome subset. PLoS One 2012, 7:e47891. 10.1371/journal.pone.0047891, 3498272, 23155374.
17. Nancy AL, Shoenfeld Y. Chronic fatigue syndrome with autoantibodies-the result of an augmented adjuvant effect of hepatitis-B vaccine and silicone implant. Autoimmun Rev 2008, 8:52-55. 10.1016/j.autrev.2008.07.026, 18725327.
18. Rosenblum H, Shoenfeld Y, Amital H. The common immunogenic etiology of chronic fatigue syndrome: from infections to vaccinesvia adjuvants to the ASIA syndrome. Infect Dis Clin North Am 2011, 25:851-863. 10.1016/j.idc.2011.07.012, 22054760.
19. Zuckerman AJ. Safety of hepatitis B vaccines. Travel Med Infect Dis 2004, 2:81-84. 10.1016/j.tmaid.2004.03.009, 17291963.
20. Prinsen H, de Vries IJ, Torensma R, Pots JM, Mulder SF, van Herpen CM, Elving LD, Bleijenberg G, Stelma FF, van Laarhoven HW. Humoral and cellular immune responses after influenza vaccination in patients with chronic fatigue syndrome. BMC Immunol 2012, 13:71. 10.1186/1471-2172-13-71, 3534525, 23244635.
21. Carruthers BM, van de Sande MI, De Meirleir KL, Klimas NG, Broderick G, Mitchell T, Staines D, Powles AC, Speight N, Vallings R, Bateman L, Baumgarten-Austrheim B, Bell DS, Carlo-Stella N, Chia J, Darragh A, Jo D, Lewis D, Light AR, Marshall-Gradisbik S, Mena I, Mikovits JA, Miwa K, Murovska M, Pall ML, Stevens S. Myalgic encephalomyelitis: International Consensus Criteria. J Intern Med 2011, 270:327-338. 10.1111/j.1365-2796.2011.02428.x, 3427890, 21777306.
22. Byrnes A, Jacks A, Dahlman-Wright K, Evengard B, Wright FA, Pedersen NL, Sullivan PF. Gene expression in peripheral blood leukocytes in monozygotic twins discordant for chronic fatigue: no evidence of a biomarker. PLoS One 2009, 4:e5805. 10.1371/journal.pone.0005805, 2688030, 19503787.
23. Zhang A, Sun H, Wang P, Wang X. Salivary proteomics in biomedical research. Clin Chim Acta 2013, 415:261-265.
24. Baldini C, Giusti L, Ciregia F, Da Valle Y, Giacomelli C, Donadio E, Sernissi F, Bazzichi L, Giannaccini G, Bombardieri S, Lucacchini A. Proteomic analysis of saliva: a unique tool to distinguish primary Sjögren's syndrome from secondary Sjögren's syndrome and other sicca syndromes. Arthritis Res Ther 2011, 13:R194. 10.1186/ar3523, 3334644, 22117835.
25. Baldini C, Giusti L, Ciregia F, Da Valle Y, Giacomelli C, Donadio E, Ferro F, Galimberti S, Donati V, Bazzichi L, Bombardieri S, Lucacchini A. Correspondence between salivary proteomic pattern and clinical course in primary Sjögren syndrome and non-Hodgkin's lymphoma: a case report. J Transl Med 2011, 9:188. 10.1186/1479-5876-9-188, 3223154, 22047044.
26. Giusti L, Baldini C, Ciregia F, Giannaccini G, Giacomelli C, De Feo F, Delle Sedie A, Riente L, Lucacchini A, Bazzichi L, Bombardieri S. Is GRP78/BiP a potential salivary biomarker in patients with rheumatoid arthritis. Proteomics Clin Appl 2010, 4:315-324. 10.1002/prca.200900082, 21137052.
27. Bazzichi L, Ciregia F, Giusti L, Baldini C, Giannaccini G, Giacomelli C, Sernissi F, Bombardieri S, Lucacchini A. Detection of potential markers of primary fibromyalgia syndrome in human saliva. Proteomics Clin Appl 2009, 3:1296-1304. 10.1002/prca.200900076, 21136951.
28. Giusti L, Baldini C, Bazzichi L, Ciregia F, Tonazzini I, Mascia G, Giannaccini G, Bombardieri S, Lucacchini A. Proteome analysis of whole saliva: a new tool for rheumatic diseases-the example of Sjögren's syndrome. Proteomics 2007, 7:1634-1643. 10.1002/pmic.200600783, 17436266.
29. Aude-Garcia C, Collin-Faure V, Luche S, Rabilloud T. Improvements and simplifications in in-gel fluorescent detection of proteins using ruthenium II tris-(bathophenanthroline disulfonate): the poor man's fluorescent detection method. Proteomics 2011, 11:324-328. 10.1002/pmic.201000370, 21204259.
30. Scherl A, Tsai YS, Shaffer SA, Goodlett DR. Increasing information from shotgun proteomic data by accounting for misassigned precursor ion masses. Proteomics 2008, 8:2791-2797. 10.1002/pmic.200800045, 18655048.
31. Giusti L, Iacconi P, Da Valle Y, Ciregia F, Ventroni T, Donadio E, Giannaccini G, Chiarugi M, Torregrossa L, Proietti A, Basolo F, Lucacchini A. A proteomic profile of washing fluid from the colorectal tract to search for potential biomarkers of colon cancer. Mol Biosyst 2012, 8:1088-1099. 10.1039/c2mb05394b, 22294321.
32. Schutzer SE, Angel TE, Liu T, Schepmoes AA, Clauss TR, Adkins JN, Camp DG, Holland BK, Bergquist J, Coyle PK, Smith RD, Fallon BA, Natelson BH. Distinct cerebrospinal fluid proteomes differentiate post-treatment lyme disease from chronic fatigue syndrome. PLoS One 2011, 6:e17287. 10.1371/journal.pone.0017287, 3044169, 21383843.
33. Baraniuk JN, Casado B, Maibach H, Clauw DJ, Pannell LK, Hess SS. A Chronic Fatigue Syndrome - related proteome in human cerebrospinal fluid. BMC Neurol 2005, 5:22. 10.1186/1471-2377-5-22, 1326206, 16321154.
34. Bhattacharjee M, Botting CH, Sillanpää MJ. Bayesian biomarker identification based on marker-expression proteomics data. Genomics 2008, 92:384-392. 10.1016/j.ygeno.2008.06.006, 18657605.
35. Giusti L, Bazzichi L, Baldini C, Ciregia F, Mascia G, Giannaccini G, Del Rosso M, Bombardieri S, Lucacchini A. Specific proteins identified in whole saliva from patients with diffuse systemic sclerosis. J Rheumatol 2007, 34:2063-2069.
36. Kim SH, Lessner SM, Sakurai Y, Galis ZS. Cyclophilin A as a novel biphasic mediator of endothelial activation and dysfunction. Am J Pathol 2004, 164:1567-1574. 10.1016/S0002-9440(10)63715-7, 1615642, 15111303.
37. Castro AP, Carvalho TM, Moussatché N, Damaso CR. Redistribution of cyclophilin A to viral factories during vaccinia virus infection and its incorporation into mature particles. J Virol 2003, 77:9052-9068. 10.1128/JVI.77.16.9052-9068.2003, 167230, 12885921.
38. He H, Mou Z, Li W, Fei L, Tang Y, Zhang J, Yan P, Chen Z, Yang X, Shen Z, Li J, Wu Y. Proteomic methods reveal cyclophilin a functions as a host restriction factor against rotavirus infection. Proteomics 2013, doi: 10.1002/pmic.201100579.
39. Tian X, Zhao C, Zhu H, She W, Zhang J, Liu J, Li L, Zheng S, Wen YM, Xie Y. Hepatitis B virus (HBV) surface antigen interacts with and promotes cyclophilin a secretion: possible link to pathogenesis of HBV infection. J Virol 2010, 84:3373-3381. 10.1128/JVI.02555-09, 2838095, 20089655.
40. Emmerson CD, van der Vlist EJ, Braam MR, Vanlandschoot P, Merchiers P, de Haard HJ, Verrips CT, Henegouwen PM V, Dolk E. Enhancement of Polymeric Immunoglobulin Receptor Transcytosis by Biparatopic VHH. PLoS One 2011, 6:e26299. 10.1371/journal.pone.0026299, 3194793, 22022593.
41. Asano M, Komiyama K. Polymeric immunoglobulin receptor. J Oral Sci 2011, 53:147-156. 10.2334/josnusd.53.147, 21712618.
42. Takiguchi H, Endo S, Omagari D, Okabayashi K, Watanabe T, Asano M, Komiyama K. Reduced production of polymeric immunoglobulin receptor in murine dextran sodium sulfate-induced colitis. J Oral Sci 2012, 54:23-32. 10.2334/josnusd.54.23, 22466883.
43. Murthy AK, Dubose CN, Banas JA, Coalson JJ, Arulanandam BP. Contribution of polymeric immunoglobulin receptor to regulation of intestinal inflammation in dextran sulfate sodium-induced colitis. J Gastroenterol Hepatol 2006, 21:1372-1380.
44. Brenu EW, van Driel ML, Staines DR, Ashton KJ, Hardcastle SL, Keane J, Tajouri L, Peterson D, Ramos SB, Marshall-Gradisnik SM. Longitudinal investigation of natural killer cells and cytokines in chronic fatigue syndrome/myalgic encephalomyelitis. J Transl Med 2012, 10:88. 10.1186/1479-5876-10-88, 3464733, 22571715.
45. Brenu EW, van Driel ML, Staines DR, Ashton KJ, Ramos SB, Keane J, Klimas NG, Marshall-Gradisnik SM. Immunological abnormalities as potential biomarkers in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis. J Transl Med 2011, 9:81. 10.1186/1479-5876-9-81, 3120691, 21619669.
46. Al-Haddad S, Zhang Z, Leygue E, Snell L, Huang A, Niu Y, Hiller-Hitchcock T, Hole K, Murphy LC, Watson PH. Psoriasin (S100A7) expression and invasive breast cancer. Am J Pathol 1999, 155:2057-2066. 10.1016/S0002-9440(10)65524-1, 1866920, 10595935.
47. Jinquan T, Vorum H, Larsen CG, Madsen P, Rasmussen HH, Gesser B, Etzerodt M, Honore B, Celis JE, Thestrup-Pedersen K. Psoriasin: a novel chemotactic protein. J Invest Dermatol 1996, 107:5-10. 10.1111/1523-1747.ep12294284, 8752830.
48. Wolf R, Howard OM, Dong HF, Voscopoulos C, Boeshans K, Winston J, Divi R, Gunsior M, Goldsmith P, Ahvazi B, Chavakis T, Oppenheim JJ, Yuspa SH. Chemotactic activity of S100A7 (Psoriasin) is mediated by the receptor for advanced glycation end products and potentiates inflammation with highly homologous but functionally distinct S100A15. J Immunol 2008, 181:1499-1506. 2435511, 18606705.
49. Nasser MW, Qamri Z, Deol YS, Ravi J, Powell CA, Trikha P, Schwendener RA, Bai XF, Shilo K, Zou X, Leone G, Wolf R, Yuspa SH, Ganju RK. S100A7 enhances mammary tumorigenesis through upregulation of inflammatory pathways. Cancer Res 2012, 72:604-615. 10.1158/0008-5472.CAN-11-0669, 3271140, 22158945.
50. Magister S, Kos J. Cystatins in immune system. J Cancer 2013, 4:45-56. 10.7150/jca.5044, 3564246, 23386904.
51. Fábián TK, Hermann P, Beck A, Fejérdy P, Fábián G. Salivary defense proteins: their network and role in innate and acquired oral immunity. Int J Mol Sci 2012, 13:4295-4320. 10.3390/ijms13044295, 3344215, 22605979.
52. Dickinson DP. Salivary (SD-type) cystatins: over one billion years in the making-but to what purpose?. Crit Rev Oral Biol Med 2002, 13:485-508. 10.1177/154411130201300606, 12499242.
53. Zhao J, Meyerkord CL, Du Y, Khuri FR, Fu H. 14-3-3 proteins as potential therapeutic targets. Semin Cell Dev Biol 2011, 22:705-712. 10.1016/j.semcdb.2011.09.012, 3207012, 21983031.
54. Matsuo K, Saburi M, Ishikawa H, Tei K, Hosokawa Y, Fujii C, Mizuno T, Nakagawa M. Sjögren syndrome presenting with encephalopathy mimicking Creutzfeldt-Jakob disease. J Neurol Sci 2013, 326:100-103. 10.1016/j.jns.2013.01.005, 23333237.
55. Muayqil T, Gronseth G, Camicioli R. Evidence-based guideline: diagnostic accuracy of CSF 14-3-3 protein in sporadic Creutzfeldt-Jakob disease: report of the guideline development subcommittee of the American Academy of Neurology. Neurology 2012, 79:1499-1506. 10.1212/WNL.0b013e31826d5fc3, 3525296, 22993290.
56. Eckardt K, Schober A, Platzbecker B, Mracek T, Bing C, Trayhurn P, Eckel J. The adipokine zinc-α2-glycoprotein activates AMP kinase in human primary skeletal muscle cells. Arch Physiol Biochem 2011, 117:88-93. 10.3109/13813455.2011.560950, 21457004.
57. Fulle S, Pietrangelo T, Mancinelli R, Saggini R, Fanò G. Specific correlations between muscle oxidative stress and chronic fatigue syndrome: a working hypothesis. J Muscle Res Cell Motil 2007, 28:355-362. 10.1007/s10974-008-9128-y, 18274865.
58. Russell ST, Tisdale MJ. Mechanism of attenuation of skeletal muscle atrophy by zinc-alpha2-glycoprotein. Endocrinology 2010, 151:4696-4704. 10.1210/en.2010-0532, 20702573.